RecallRadar

FDA Drug recall D-0245-2025

Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc.,…

On 2025-02-26 the FDA classified a Class I recall of Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc.,… by Alvogen, citing defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0245-2025
ClassificationClass I
Statusongoing
Initiated2025-01-31
Published2025-02-26
Last updated2026-09-13 11:52 UTC
CompanyAlvogen
DistributionUS

Product

Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.

Reason

Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.

Identifiers

ndc47781-423-11
ndc47781-423-47
ndc47781-424-11
ndc47781-424-47
ndc47781-426-11
ndc47781-426-47
ndc47781-427-11
ndc47781-427-47
ndc47781-428-11
ndc47781-428-47
code_infoLot #: 108319, Exp: 04/30/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0245-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.